# Clinical Trial Using Humira in Netherton Syndrome

> **NCT02113904** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 11 (actual)

## Conditions studied

- Netherton Syndrome

## Interventions

- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT02113904
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-27
- **Primary completion:** 2016-12-20
- **Final completion:** 2017-09-21
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02113904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02113904, "Clinical Trial Using Humira in Netherton Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02113904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*